Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Strong annual results from Springfield, Fiske

Tue, 14th Sep 2021 17:46

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Springfield Properties PLC - Scottish housebuilder - For the year ended May 31, pretax profit rises 81% to GBP18.5 million from GBP10.2 million, on revenue growing 51% year-on-year to GBP216.7 million from GBP143.5 million, driven by higher sales and demand in private and affordable housing. Total completes increases to 973 homes from 727, as the average selling price for private housing rises to GBP244,000 from GBP236,000. Declares dividend of 5.75 pence, more than doubled from 2.0p the prior year.

----------

Harworth Group PLC - Rotherham, Yorkshire-based land regenerator - For the six months ended June 30, swings to pretax profit of GBP80.1 million from loss of GBP3.7 million, due to revaluation gains on properties and assets of GBP105.7 million. In addition, revenue declined 20% year-on-year to GBP18.9 million from GBP23.7 million due to later starts on site in 2020 due to the pandemic. As at June 30, net asset value per share was 167.8p, up from 142.2p the same date the year prior, while the portfolio value stands at GBP748.0 million from GBP618.2 million at the end of December. Declares interim dividend of 0.36 pence per share, up from 0.33p a year prior.

----------

Aberdeen Smaller Companies Income Trust PLC - invests in UK small-cap stocks - Net asset value total return for the six months ended June 30 was 20.1%, compared to the Numis Smaller Companies excluding Investment Trust index, which returned 17.4%. As at June 30, NAV per share is 413.97 pence, up 19% from 348.91p at the end of December.

----------

Henderson High Income Trust PLC - pure income trust investing in dividend-paying UK companies - For the first half of 2021, net asset value total return was 12.3%, while its benchmark - a composite made up 80% of the FTSE All-Share index and 20% of the ICE BofAML Sterling Non-Gilts index - returned 8.4%. At the end of June, NAV per share was 171.6 pence, up % from 157.3p at December 31.

----------

Phoenix Global Resources PLC - upstream oil and gas company - For the first half of 2021, pretax loss narrows to USD3.9 million from USD62.1 million the same period a year before, on revenue which grows 45% year-on-year to USD36.1 million from USD24.9 million. Revenue growth was due to higher oil sales during the period, mainly through the shut-in of production due to Covid-19 in 2020 and the rise in oil prices to USD47.03 per barrel to USD39.19.

----------

Infrastructure India PLC - investor in infrastructure assets in India's energy and transport sectors - Renewable assets are currently operating in line with expectations due to steady demand for power. As at August 31, cash position stands at USD3.5 million, and the company continues to evaluate options and find alternative sources of financing. As at March 31, expects to report net asset value per share between 10p to 13p. Applies to AIM for three-month extension for its annual results, which is expected to be published in October.

----------

ThinkSmart Ltd - Australian digital payments platform - For the year ended June 30, pretax profit rises 35% to GBP71.7 million from GBP53.1 million the year before, mainly due to a higher gain on financial instruments on the revaluation of the group's investment in ClearPay Finance Ltd due to a strong performance from the investee. However, revenue dropped 31% year-on-year to GBP4.3 million from GBP6.3 million on a drop in leasing volumes.

----------

Porvair PLC - Norfolk, England-based filtration and environmental technology firm - Trading for the third quarter ended August 31 is ahead of expectations, with healthy order books in industrial processes, laboratory and aluminium. However, due to supply chain issues, company has deemed it too early to determine its annual performance.

----------

Good Energy Group PLC - Chippenham, England-based energy company - For the first half of 2021, swings to pretax profit of GBP4.8 million from loss of GBP1.1 million the same period a year before, on revenue which rises 1.4% year-on-year to GBP68.4 million from GBP67.5 million on an increase in customer numbers. Intends to recommend a dividend payment for 2021, and will pay 0.75p per share should the hostile offer by Ecotricity Group Ltd lapse or be withdrawn.

----------

Ovoca Bio PLC - Women's health-focused biopharmaceutical company - For the six months ended June 30, pretax loss widens to USD3.7 million from USD2.2 million a year before, due to a rise in administrative expenses and the generation of no revenue during the period.

----------

Kistos PLC - London-based energy sector investor - For the 37 weeks ended June 30, reports pretax loss of EUR5.2 million, on revenue of EUR6.6 million. On a proforma basis following the acquisition of Tulip Oil Netherlands BV, revenue rose 97% year-on-year to EUR33.7 million from EUR17.1 million. despite production falling 28% to 1,598 megawatt hours from 2,230MWh.

----------

MaxCyte Inc - Maryland, US-based biotechnology company - For the first half of 2021, net loss widens to USD11.5 million from USD6.1 million the year before, due to higher operating expenses through an increased headcount and higher stock-based compensation, as well as a rise in legal expenses. Meanwhile, revenue grows 25% to USD13.6 million from USD10.9 million, through higher sales in cell therapy and drug discovery markets.

----------

Property Franchise Group PLC - UK-based lettings and estate agency franchising firm - For the six months ended June 30, pretax profit rises 57% to GBP3.1 million from GBP2.0 million the same period a year prior, as well as a 54% increase from the first half of 2019. This is on revenue which more than doubles to GBP11.1 million from GBP5.1 million, on higher managed services fees and increased sales activity. Raises interim dividend by 81% to 3.8 pence from 2.1p. Looking ahead, expects 2021 annual profit performance to be ahead of market expectations.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - For the year ended June 30, pretax loss widens to GBP11.5 million from GBP5.3 million the year before due to higher expenses as the company sets up key studies designed to increased the value of Diurnal's pipeline. Revenue declines % year-on-year to GBP4.4 million from GBP6.3 million, driven by a drop in product sales and licensing income.

----------

Made.com Group PLC - London-based furniture retailer - For the six months ended June 30, pretax loss narrows to GBP10.1 million from GBP15.2 million, as revenue grows 61% year-on-year to GBP171.0 million from GBP106.3 million, driven by a 54% increase in gross sales to GBP213.9 million supported by high levels of market demand. Looking ahead, revenue for 2021 is expects to be around GBP410 million, reflecting a 65% increase.

----------

Fiske PLC - London-based stockbroker and investment manager - For the year ended May 31, pretax profit is GBP610,000, swinging from a loss of GBP127,000 the year before, on revenue which grows 13% year-on-year to GBP6.1 million from GBP5.4 million.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Dec 2019 13:19

Diurnal submits application for 'Alkindi Sprinkle' to US FDA

(Sharecast News) - Specialty pharmaceutical company Diurnal Group has submitted a 'New Drug Application' (NDA) to the US Food and Drug Administration (FDA), for the regulatory approval of 'Alkindi Sprinkle', or hydrocortisone granules in capsules for opening, as a replacement therapy of adrenal insufficiency in infants, children and adolescents in the US, it announced on Monday.

Read more
21 Nov 2019 11:36

Diurnal Primary Focus Remains On Progressing Flagship Products

Diurnal Primary Focus Remains On Progressing Flagship Products

Read more
20 Nov 2019 11:36

Diurnal To Explore Further Tests As Testosterone Treatment Does Well

Diurnal To Explore Further Tests As Testosterone Treatment Does Well

Read more
24 Sep 2019 11:21

Diurnal Loss Narrows On Research Expenses And Alkindi Launch

Diurnal Loss Narrows On Research Expenses And Alkindi Launch

Read more
14 Jun 2019 14:26

Diurnal Shareholders Approve Placing, Open Offer Worth GBP6 Million (ALLISS)

(Alliance News) - Pharmaceutical firm Diurnal Group PLC's shareholders on Friday approved its GBP5.9 million fundraise completed earlier in the day.Diurnal, which focuses on patients or

Read more
28 May 2019 13:32

Diurnal Group launches placing and open offer to fund drug development

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced a conditional placing of new ordinary shares in the company and the launch of an open offer on Tuesday, in order to raise funds to progress the development and commercialisation of its products.

Read more
28 May 2019 10:49

Diurnal Raises GBP5 Million Via Placing; Plans GBP1 Million Open Offer (ALLISS)

LONDON (Alliance News) - Diurnal Group PLC said Tuesday it has raised around GBP5.4 million via a 20.6 million share placing priced at 26 pence per share and announced an open offer to raise up to

Read more
10 May 2019 09:36

Polar Capital Global Healthcare Lags Behind Benchmark In First Half

LONDON (Alliance News) - Polar Capital Global Healthcare Trust PLC said on Friday it lagged against its benchmark for the first half of its financial year, as the healthcare trust underperformed a

Read more
24 Apr 2019 15:50

Diurnal gets orphan drug designation for Alkindi in Australia

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Wednesday that its 'Alkindi' product - hydrocortisone granules in capsules for opening - had been granted orphan drug designation in Australia by the Therapeutic Goods Administration, for the indication 'replacement therapy of adrenal insufficiency (AI) in infants, children and adolescents from birth to 18 years old'.

Read more
24 Apr 2019 10:44

Diurnal Gets Orphan Drug Designation For Alkindi In Australia

LONDON (Alliance News) - Diurnal Group PLC on Wednesday said its adrenal insufficiency drug Alkindi has been granted a second patent and orphan drug designation in Australia.Shares in were

Read more
28 Mar 2019 08:35

Diurnal soars after securing Nordic distribution deal

(Sharecast News) - Diurnal's shares leapt on Thursday despite a widened interim loss as the company landed a marketing and distribution deal for its Alkindi treatment in Scandinavia.

Read more
21 Mar 2019 16:11

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 22 March Sanne GroupFull Year ResultsSmiths GroupHalf Year BootFull Year

Read more
20 Mar 2019 10:33

Diurnal Group upbeat following FDA meeting over 'Alkindi'

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Wednesday that, following a "positive" meeting with the US Food and Drug Administration (FDA), it intended to submit a new drug application (NDA) for 'Alkindi' (hydrocortisone granules in capsules for opening) in the fourth quarter of 2019 as previously planned, with final acceptance of the filing by the FDA expected in 2020.

Read more
25 Feb 2019 10:39

Diurnal expecting Israel launch of 'Alkindi' next year

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Monday that its marketing and distribution partner, Medison Pharma has successfully submitted a market authorisation application (MAA) for its 'Alkindi' (hydrocortisone granules in capsules for opening) product to the Ministry of Health in Israel.

Read more
10 Jan 2019 12:35

Diurnal Granted US Patent But Unsure Why Share Price Has Tripled

LONDON (Alliance News) - Diurnal Group PLC said on Thursday that, aside from the granting of a patent, it is unsure as to why its share price has tripled.Shares were 188% higher on Thursday

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.